Jennifer is currently accepting new patients and
generally has the soonest appointment availability.
For most new patients, we recommend scheduling with
Jennifer as the first choice.
Dr. Gabriella Farkas, MD, PhD
Limited Availability
Psychiatrist · MD, PhD
Dr. Farkas continues to see new patients on a more
limited basis. Patients specifically seeking an
appointment with Dr. Farkas may view her availability
in the scheduling portal.
On the scheduling screen, Jennifer Reilly will appear
first. Select your preferred clinician to continue
with available appointment times.
PMDD (Premenstrual Dysphoric Disorder) is one of the few psychiatric conditions where intermittent medication dosing has substantial evidence. Unlike depression or anxiety — where continuous treatment is the standard — PMDD can be effectively treated with SSRIs given only during the luteal phase of the menstrual cycle. This unique treatment option matters for women who don’t want continuous medication.
According to research summarized by the American College of Obstetricians and Gynecologists, both luteal-phase and continuous SSRI strategies are evidence-based for PMDD — with each having advantages depending on patient circumstances.
PMDD has unique treatment options — including intermittent dosing strategies.
Why PMDD Treatment Differs from Standard Depression
PMDD is biologically tied to the menstrual cycle — symptoms emerge in the luteal phase (after ovulation) and resolve within days of menstruation onset. This pattern allows treatment approaches not possible with other mood disorders:
Symptoms have predictable onset and offset
Trigger (progesterone metabolite sensitivity) is identifiable
SSRIs work much faster in PMDD than in depression (days, not weeks)
Intermittent dosing can produce sustained response
Treatment Options
Continuous SSRI dosing
Daily SSRI throughout the cycle. Effective for 60-70% of PMDD patients. Particularly useful when:
Patient has coexisting depression or anxiety
Cycle tracking is difficult
Symptoms aren’t perfectly cyclical
Patient prefers consistent dosing
Luteal-phase only dosing
SSRI started 14 days before expected menses, continued through Day 1 of menses. Effective for many PMDD patients with similar response rates to continuous dosing.
Advantages:
Reduced total medication exposure
Lower side effect burden over time
Avoidance of long-term SSRI use for women who prefer this
Useful for women planning pregnancy
Requires reliable cycle tracking. Less practical for women with irregular cycles.
Symptom-onset dosing
SSRI started when symptoms begin each cycle, continued until menses. Useful when symptom timing varies.
Specific SSRI considerations
Sertraline — FDA-approved for PMDD; commonly used; flexible dosing
Fluoxetine — FDA-approved for PMDD as Sarafem; long half-life makes it forgiving
Paroxetine — FDA-approved for PMDD; effective but withdrawal symptoms can be challenging with intermittent use
Escitalopram — Off-label but commonly used; well-tolerated
When SSRIs Don’t Provide Adequate Response
SNRI options
Venlafaxine has evidence for PMDD when SSRIs haven’t worked. Duloxetine may also help.
Hormonal options
Some women benefit from hormonal suppression of ovulation:
Continuous oral contraceptives — eliminate cycle by suppressing ovulation
Drospirenone-containing OCs — specifically studied for PMDD
GnRH agonists — chemical menopause; reserved for severe cases
Oophorectomy — surgical option only for the most severe, treatment-refractory cases after careful consideration
Not necessarily — luteal-phase dosing is a valid option for many women. Continuous or intermittent both work; selection depends on your situation.
How quickly does luteal-phase dosing work?
SSRIs work much faster in PMDD than in depression — often within 2-3 days. By the second or third cycle of treatment, most patients see substantial response.
Can I get pregnant while on PMDD treatment?
Yes — most SSRIs are compatible with pregnancy planning. Discuss specific medication choice with your provider. See our related articles on PMDD basics and perinatal mental health.
What about hormonal options?
For some women, continuous OCs or other hormonal approaches work well — particularly when SSRIs haven’t provided adequate response. Decision involves coordination with gynecology.
PMDD-specific care produces PMDD-specific results.
Effective treatment options exist — including approaches unique to this condition.